Therefore, in the present research, we aimed to establish a method for the direct identification of the HER2 interactome from HER2-positive breast cancer specimens using the RIME technique and to assess its potential for identifying novel interactants that could serve as diagnostic and prognostic markers. The gene discussed is ERBB2; the disease is breast carcinoma.